High blood pressure: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· Novo Nordisk A/S· Updated 4 Nov 2026

  “Interim futility analysis showed primary endpoint not achieved”Registry text, quoted unchanged. Source

• Terminated

  mHealth for Hypertensive Disorder of Pregnancy

  NCT05995106· Seoul National University Hospital· Updated 2 Nov 2026

  “Maintenance of the Heart4U application was discontinued, and enrollment was stopped.”Registry text, quoted unchanged. Source

• Withdrawn

  Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

  NCT06608472· Eurofarma Laboratorios S.A.· Updated 26 Oct 2026

  “Strategic change in development priorities.”Registry text, quoted unchanged. Source

• Terminated

  Baroloop Multicenter Trial (Baroloop MCT)

  NCT06518915· neuroloop GmbH· Updated 20 Oct 2026

  “Terminated following a device deficiency in 1 subject. Benefit-risk and development assessments did not support continuation within the planned framework. Root cause analysis pending.”Registry text, quoted unchanged. Source

• Terminated

  Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study

  NCT04218773· Yale University· Updated 14 Oct 2026

  “The study was terminated prematurely due to lack of continued funding.”Registry text, quoted unchanged. Source

• Terminated

  Role of L-citrulline in Prevention of Pregnancy Associated Hypertension

  NCT04979793· The University of Texas Medical Branch, Galveston· Updated 30 Sept 2026

  “At the request of the PI”Registry text, quoted unchanged. Source

• Withdrawn

  A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease

  NCT07223502· Sarfez Pharmaceuticals, Inc.· Updated 22 Sept 2026

  “No recruitment”Registry text, quoted unchanged. Source

• Withdrawn

  Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

  NCT03508739· University of Pennsylvania· Updated 21 Sept 2026

  “We do not have active funding.”Registry text, quoted unchanged. Source

• Withdrawn

  Glucose and Blood Pressure During Pregnancy

  NCT04979312· Mayo Clinic· Updated 15 Sept 2026

  “Device Unavailable”Registry text, quoted unchanged. Source

• Terminated

  Contributions to Hypertension With Androgen Deprivation Therapy

  NCT05700903· University of Colorado, Denver· Updated 2 Sept 2026

  “Study completed”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  NCT06742723· AstraZeneca· Source

• Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle

  NCT06002165· University of North Carolina, Chapel Hill· Source

• A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control

  NCT07915752· Northwestern University· Source

• A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

  NCT03892265· Washington University School of Medicine· Source

• Dine and DASH Into Wellness Pilot Study

  NCT07175896· Duke University· Source

• Trial Phase: Syndemic Adapted Medly Uganda

  NCT07525271· Yale University· Source

• Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

  NCT06831162· Vanderbilt University Medical Center· Source

• Furosemide vs Placebo in Severe Preeclampsia Postpartum

  NCT07648251· Universidad Nacional Autonoma de Honduras· Source

• A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

  NCT07919405· Novo Nordisk A/S· Source

• Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health

  NCT07918508· Florida International University· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 12
• Organoids 1
• Mendelian Randomization Analysis 84
• CRISPR-Cas Systems 2
• Gene Expression Profiling 52
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 2
• Exome Sequencing 10
• Proteomics 44
• Metabolomics 45
• Mass Spectrometry 3
• Flow Cytometry 4
• Immunohistochemistry 24
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 6
• Magnetic Resonance Imaging 123
• Machine Learning 100
• Deep Learning 13
• Cohort Studies 414
• Genome-Wide Association Study 81

• Interpretable Machine Learning for Predicting Early Onset Hypertension in the US.

  Prev Chronic Dis, Oct 2026

• Association between the triacylglycerol-glucose index, TyG-BMI and hypertension in children and adolescents: a cross-sectional study with machine-learning-based risk stratification.

  Front Endocrinol (Lausanne), Oct 2026

• A Machine Learning Framework for Predicting Functional Status and Estimating Health Care Costs in Pulmonary Arterial Hypertension: Retrospective Cohort Study.

  JMIR Med Inform, Oct 2026

• Integrated multi-omics and machine learning identify core mechanobiology-associated immune genes in pulmonary arterial hypertension.

  Front Immunol, Oct 2026

• Food-Derived Antihypertensive Peptides: A Comprehensive Review of Preparation Strategies, Multitarget Mechanisms, and Machine Learning Advancements.

  J Agric Food Chem, Sept 2026

• A Drug-Referenced Machine-Learning Framework for Prioritizing Korean Herbal Formulations in Hypertension Using Linear SVM and Graph Convolutional Networks.

  Int J Mol Sci, Sept 2026

• Development and Validation of a Machine Learning-Based Model for Predicting All-Cause Mortality Risk in Patients With Type 2 Diabetes Mellitus Combined With Hypertension: National Cohort Study.

  JMIR Med Inform, Sept 2026

• Machine learning and deep learning-based prediction of hypertension and analysis of its major risk factors in Bangladesh.

  PLoS One, Sept 2026

• Evaluation of a National Health Service Machine-Learning Model for Hypertension Case-Finding: Retrospective Cohort Study.

  J Med Internet Res, Sept 2026

• Interpretable machine learning-enabled risk stratification for pulmonary arterial hypertension associated with unrepaired congenital heart disease: results from a national prospective registry.

  Int J Cardiol, Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.